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ABSTRACT
DNA damage assays have various limitations in
types of lesions detected, sensitivity, specificity and
samples that can be analyzed. The Northern Lights
Assay (NLA) is based on 2D Strandness-Dependent
Electrophoresis (2D-SDE), a technique that sepa-
rates nucleic acids based on length, strandness,
structure and conformation changes induced by
damage. NLA is run on a microgel platform in 20–
25 min. Each specimen is analyzed in pairs of non-
digested DNA to detect single- and double-stranded
breaks (DSBs) and Mbo I-digested DNA to detect
other lesions. We used NLA to evaluate DNA in so-
lution and isolated from human cells treated with
various genotoxic agents. NLA detected and distin-
guished between single- and DSBs, interstrand and
intrastrand DNA crosslinks, and denatured single-
stranded DNA. NLA was sufficiently sensitive to de-
tect biologically relevant amount of DNA damage.
NLA is a versatile, sensitive and simple method for
comprehensive and simultaneous analysis of mul-
tiple types of damage, both in purified DNA and in
DNA isolated from cells and body fluids. NLA can be
used to evaluate DNA quality in biosamples, monitor
complex molecular procedures, assess genotoxicity,
diagnose genome instability, facilitate cancer thera-
nostics and in basic nucleic acids research.
INTRODUCTION
Cells are constantly exposed to genotoxic stress arising ei-
ther from cell metabolism or external genotoxic agents. The
damage that arises from genotoxic stress, including single-
stranded breaks (SSB), double-stranded breaks (DSB),
crosslinks and bulky adducts, can lead to mutagenesis or
cell death if not repaired. Consequently, DNA damage as-
sessment plays an important role in many areas of basic
biomedical science and clinical medicine. It also has mul-
tiple applications in quality assessment of biosamples and
in complex molecular procedures.
Detection of different types of DNA damage is impor-
tant for diagnosis of genetic diseases associated with aber-
rant DNA repair. Examples include defects in crosslink re-
pair in patients with Fanconi anemia (FA) (1), UV-induced
damage repair in xeroderma pigmentosum patients (2) and
ionizing radiation-induced DSB repair in ataxia telangiec-
tasia patients (3). The efficacy of many clinically impor-
tant cancer chemotherapeutic agents is thought to depend
on their capacity to form DNA damage (4–6). Detection
of the DNA damage induced by these agents can be used
to estimate their therapeutic efficacy or side effects. Ex-
amples are the crosslinking agents cisplatin, used to treat
ovarian, testicular and cervical cancers; carboplatin, used
mainly for ovarian cancer; mitomycin C (MMC), used to
treat oesophageal and bladder cancer; and melphalan, a ni-
trogen mustard derivative used to treat multiple myeloma
(7). Other chemotherapeutic agents lead to formation of
DNA breaks (8–10). These include PARP inhibitors (10)
which are in clinical trials as chemotherapeutic agents to
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treat BRCA-deficient breast cancer, and topoisomerase in-
hibitors such as camptothecin, doxorubicin and etoposide
(6,11). In addition to causing DNA breaks, etoposide also
induces apoptosis (12) which is characterized by the forma-
tion of nucleosomal-sized DNA fragments.
Currently, there are several methods for detecting DNA
damage and repair in vitro and in biological systems. The
comet assay is a versatile technique to detect DNA dam-
age at the single cell level (13). Originally developed to de-
tect DNA breaks (13,14), it was subsequently modified to
detect other types of DNA damage (15), including inter-
strand DNA crosslinks, UV-damage and oxidative damage.
The alkaline elution assay (16) detects SSB in cells by mea-
suring the rate of DNA elution from cellulose filter mem-
branes. The fluorometric alkaline DNA unwinding assay
(FADU assay) is based on partial denaturation of double-
stranded DNA (dsDNA) under controlled alkaline condi-
tions where breaks serve as starting positions of unwinding
during the alkaline denaturation of chromosomal DNA in
a cell lysate (17). In addition, DNA breaks and degradation
during apoptosis can be detected in situ with the Terminal
deoxynucleotidyl transferase (TdT) dUTP Nick-End Label-
ing (TUNEL) assay (18). The current methods for DNA
damage detection; (i) are complex or slow to perform, (ii)
do not detect many types of DNA damage simultaneously,
(iii) are not applicable for DNA in solution or cell-free DNA
from body fluids or (iv) require expensive specialized equip-
ment and expertise. A simple method that can detect and
distinguish between all major structural DNA lesions in
a quick and easy manner in both cellular DNA and cell-
free DNA would be a substantial improvement over existing
techniques.
The Northern Lights Assay (NLA) for detection of DNA
damage is based 2D Strandness-Dependent Electrophore-
sis (2D-SDE), a method used to assess quality of complex
nucleic acids samples and monitor efficiency of molecular
procedures (19–22). During the electrophoresis in the first
dimension, molecules in the sample are separated based
on their length, strandness and damage-induced conforma-
tion. Before the second dimension electrophoresis the DNA
in the gel is heat-denatured and all molecules become single-
stranded. They therefore separate only according to length
in the second dimension electrophoresis, unless they contain
interstrand crosslinks. In NLA, pairs of samples, one not
digested and the other digested with the restriction enzyme
Mbo I are analyzed. Mbo I is a four base cutter that digests
both single-stranded DNA (ssDNA) and dsDNA (23).
We designed NLA as a versatile method to detect multi-
ple kinds of DNA damage based on the known effects of
lesions on the molecular structure and migration character-
istics of DNA molecules in 2D-SDE (Figure 1 and Supple-
mentary Figure S7). In this study we evaluated the ability
of NLA to detect various types of structural DNA damage,
including interstrand and intrastrand DNA crosslinks, SSB
and DSB in addition to apoptotic degradation. We tested
the method both on DNAs damaged in solution and DNA
damaged in living cells. Our results confirm that NLA is a
simple sensitive assay for simultaneously detecting various
types of DNA damage.
MATERIALS AND METHODS
Cisplatin treatment of DNA in solution
Genomic DNA was isolated from blood with Gentra Pure-
gene Blood kit (Qiagen, cat no. 158389) according to the
manufacturer’s instructions. DNA (7.5 g) was digested
with 3 U/g DNA Mbo I (10 U/l, Thermo Scientific,
cat no. ER0812) at 37◦C for 1 h. The DNA was purified
with Amicon Ultra 30K centrifugal filters (Millipore, cat
no. UFC503024) and divided into 1 g aliquots. Treatment
of DNA with cisplatin (cis-Diamminedichloroplatinum(II))
was done according to Murray et al. (24). In a total vol-
ume of 100 l, 1 g DNA was incubated in 25 mM Tris–
HCl, pH 7.8 with 1–15 M of cisplatin (Sigma-Aldrich, cat
no. 479306), at 37◦C for 18 h in the dark. The DNA was
ethanol precipitated with sodium acetate and resuspended
in 3 l TE buffer (10 mM Tris–HCl, 1 mM ethylenedi-
aminetetraacetic acid (EDTA), pH 8.0). For denaturation
experiments, 1 g human genomic DNA, in 3 l TE, was
heated up at 94◦C for 4 min. Plasmid pUC 18 was digested
with Hinf I (Thermo Scientific, cat no. ER0801) and Ssp I
(Thermo Scientific, cat no. ER0771) 1.5 U enzyme per mi-
crogram DNA, prior to cisplatin treatment.
Induction of nicking in DNA in solution
Nicks were formed in 1 g DNA using either a range of
0.1–1 U Nt.BstNB I (NEB, cat no. R0607S) or 0.008–10 U
Nt.CviPII (NEB, cat no. R0626S) in buffer NEB 3 at 55◦C
for 1 h in total volume of 50 l.
Cy5-labeling of DNA ladder
GeneRuler 100 bp Plus ladder (Thermo Scientific,
SM0321), ranging in size from 100 to 3000 bp was labeled
with fill-in reaction, comprising 5 g DNA, 5 U T4
polymerase (Thermo Scientific, cat no. EP0061), 1 × T4
polymerase buffer (Thermo Scientific, 67 mM Tris–HCl
(pH 8.8), 6.6 mM MgCl2, 1 mM dithiothreitol (DTT), 16.5
mM (NH4)2SO4) for 1 min at 37◦C to form overhangs.
Unlabeled dATP, dGTP and dTTP, and Cy5-labeled dCTP
were then added for a final concentration of 100 M each
nucleotide, and fill-in reaction done at 37◦C for 15 min
and quenched with 1 l of 0.5 M EDTA. The Cy5-labeled
marker was purified with QIAquick PCR purification
kit (Qiagen, cat no. 28104) according to manufacturer’s
instructions.
Cell cultures and treatment
Fibroblast cell line GM3440, normal with regard to re-
pair of DNA crosslinks, was obtained from Coriell Insti-
tute for Medical Research (cat id. GM03440) (http://www.
coriell.org/). BJ foreskin fibroblasts, normal with regard
to DNA crosslink repair, were obtained from ATCC (cat
no. CRL-2522). FANCA−/− cell line complemented with
an empty vector (FANCA−/− +Vector) (25,26), or with
the FANCA gene (FANCA−/− +WT-FANCA) (25), and
FANCD1−/− cell line RA3226 fibroblasts (27) had been im-
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Figure 1. Predicted detection of different types of DNA damage with the NLA. (A) Undigested and Mbo I-digested DNA samples being tested are shown
in green after first dimension electrophoresis. (B) Results for a specimen with intact undamaged DNA. The undigested DNA sample does not migrate
into the gel efficiently and the digested sample co-migrates with dsDNA marker (red). (C) Results for a specimen with damaged DNA where various
lesions can be detected. In the undigested sample, SSB are seen as a horizontal streak extending from the DNA that is too large to migrate into the gel
and DSB generate dsDNA molecules that are small enough to co-migrate with the dsDNA marker. Many different DNA lesions can be detected in the
Mbo I-digested sample. DNA strands with interstand crosslinks remain covalently attached when denatured. They are larger and migrate slower in the
second dimension than ssDNA from originally intact dsDNA. They are therefore placed behind the arc of intact dsDNA molecules in the original sample.
DNA molecules that are bent due to monoadducts, instrastrand crosslinks, mismatches or thymidine dimers (shade), and ssDNA (diagonal line) migrate
relatively slowly compared to intact dsDNA in the first dimension, but that DNA has normal migration velocity in the second dimension. These molecules
are therefore placed in front of normal dsDNA. DNA containing ssDNA breaks gives rise to small fragments on the nicked strand after denaturation. After
2D electrophoresis the smaller fragments will be placed in front of normal dsDNA because of their small size compared to the complementary undamaged
strand.
and transformed using HPVE6 and E7 proteins. The sen-
sitivity to treatment with crosslinking agents of cell lines
BJ, FANCA−/− +Vector, FANCA−/− +WT-FANCA, and
FANCD1−/− was characterized in refs. (25–27). Monolay-
ers of cells were cultured at 37◦C in a humidified atmo-
sphere of 5% CO2 in Dulbecco’s modified Eagle’s medium
(DMEM) (Gibco) supplemented with 2 mM glutamine, 100
IU/ml penicillin, 100 IU/ml streptomycin and 10 or 15%
fetal bovine serum (FBS) (Gibco). Cell cultures (1–2 ×
106 cells) were treated with a medium containing crosslink-
ing agent for 4–24 h. Cisplatin (Sigma-Aldrich) was added
to medium without FBS. MMC (Sigma-Aldrich, cat no.
M4287), DEB (Sigma-Aldrich, cat no. 202533) or melpha-
lan (Sigma-Aldrich, cat no. M2011) were added to a com-
plete medium.
For repair experiments, the medium containing the
crosslinking agent was removed, the cells were washed twice
with 1 × PBS (phosphate-buffered saline) at 37◦C and al-
lowed to recover in medium without a crosslinking agent
for 24–120 h.
Human umbilical vein endothelial cells (HUVEC) were
kindly provided by Dr Gudrun Valdimarsdottir (Depart-
ment of Biochemistry and Molecular Biology, University of
Iceland). The HUVEC primary cells were grown in EGM-
2 medium (Lonza, cat no. CC-3162) to confluency, at pas-
sage 4. Cells were treated with 5 and 50 M etoposide (cor-
responding to 2.9 and 29 g/ml, respectively) and grown
in EGM-2 medium for 48 h. For serum-depletion, the cells
were grown in FBS-free DMEM for 4 days and control cells
were cultured in DMEM with 1% FBS for 4 days.
Monolayers of MCF-7 (ATCC), luminal breast cancer
cell line, normal with regards to BRCA1 and BRCA2,
and epithelial pancreatic adenocarcinoma cell line Capan-
1 (BRCA2−/−) (ATCC) were cultured in DMEM supple-
mented with 20% FBS. Human breast epithelial cell line
A176 (BRCA2−/+) (28) was harvested in H14 medium
(DMEM with 250 ng/ml insulin, 10 g/ml transferrin, 2.6
ng/ml sodium selenite, 10-10 M estradiol, 1.4 × 10-6 M
hydrocortisone, 5 g/ml prolactin). The cell cultures were
treated with 5 M olaparib (AZD-2281, Sigma-Aldrich, cat
no SML1858) for 48 h.
The cell cultures were detached with 0.05% trypsin
(Gibco) and genomic DNA isolated with Gentra Puregene
Cell Kit (Qiagen) protocol for cultured cells according to
the manufacturer’s instructions. After isolation, DNA was
resuspended in TLE buffer (10 mM Tris–HCl, 0.1 mM
EDTA, pH 8.0).
Cytogenetic analysis
Actively dividing cell cultures were treated with 50 nM
MMC for 24 h. The cells were arrested by adding colcemid
(0.167 g/ml final concentration) to the culture media for
2 h, followed by collection with trypsin and centrifugation,
hypotonic shock with 0.075 M KCl, and fixation in freshly
made 3:1 absolute methanol:glacial acetic acid. Cell spec-
imen suspension (3–4 drops) was placed on microscopic
slides and stained with 1:3 Leishman dye: PBS (pH 7.0) mix-
ture and analyzed under the microscope.
Two-dimensional strandness-dependent electrophoresis (2D-
SDE)
2D-SDE (19) was carried out on both minigel and micro-
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as described by Gunnarsson et al. (20). Polyacrylamide gels
(4%) were made from 30% 29:1 acrylamide:bisacrylamide
mixture (Amersham Biosciences) in 1 × tris-borate-EDTA
(TBE) and 7 M urea. Mbo I-digested DNA (1 g) con-
taining 20 ng Cy5-labeled ladder was loaded on the gel in
5% glycerol loading buffer. First dimension electrophore-
sis, was carried out in a vertical Mini-Protean II system
(Bio-Rad) at room temperature in 1 × TBE and constant
20 mA for 20 min. After the first dimension electrophore-
sis the gel was heated up to 85◦C on a dry heat-block
for 2 min. Second dimension electrophoresis was carried
out perpendicular to the first dimension in 1 × TBE at
constant 5 W at 55◦C for 14 min in a Multiphor system
(Amersham Biosciences) using paper electrode wicks. NLA
on a microgel platform was carried out on 4% polyacry-
lamide gels containing 1.25 × TBE and 7 M urea accord-
ing to Thormar et al. (29). In the first dimension, gel elec-
trophoresis was carried out at 4◦C at constant 30 mA for
11 min. Between dimensions, the gel was heated up to 85◦C
for 2 min. The second dimension electrophoresis was done
at 55◦C at constant 36 mA for 7 min. Gels were stained
post-run in 100 ml 1 × TBE buffer with 1 × ribogreen
(Invitrogen––Molecluar Probes, cat no. R11491) and an-
alyzed using the fluorescence-scanning mode of Typhoon
8610 variable mode imager (Amersham Biosciences).
Quantification of DNA damage
Fractions of intact dsDNA and damaged DNA were quan-
tified using ImageQuant 5.1 TL Toolbox v8.1 software (GE
Healthcare Life Sciences). Undigested DNA that did not
migrate efficiently into the gel was defined from the well
down to the upper edge of the 3000 bp band of the Cy5
ladder (purple in Supplementary Figure S1B and C). The
Cy5-labeled ladder was used to define the region of dsDNA
that did not overlap with damaged DNA, covering the area
flanked by the lower edge of the 100 bp ladder band and
upper edge of the 1000 bp band, with width defined by the
edges of the marker bands (green in Supplementary Figure
S1B and C). Displacement of that area immediately to the
left was used to define the area DNA migrating behind the
dsDNA (blue in Supplementary Figure S1C). The area im-
mediately to the right of the dsDNA ladder was defined ver-
tically from the edge of the 100 bp ladder band perpendicu-
lar up to the edge of the horizontal to the 2000 bp band (red
in Supplementary Figure S1C). This area included DNA
molecules with slow migration velocity compared to ds-
DNA in the first dimension electrophoresis, including ss-
DNA and bent molecules. SSB were measured by defining
an area where a streak extending from the large molecules
that were too large to migrate into the gel and extending to
a point vertically over the 100 bp band in the ladder (brown
in Supplementary Figure S1C). Quantification was a rel-
ative measurement of density within each gel area, given
in percentage. Background correction was achieved by se-
lecting a DNA-free area in the gel (Supplementary Figure
S1C), subtracting the density of that area from each DNA-
containing area and correcting for the size of each area. The
size-distribution of DNA in each fraction was estimated by
drawing a line through the ladder and extrapolating to other
parts of the gel (Supplementary Figure S1D and E). Be-
cause ssDNA fragments are placed directly above dsDNA
of the same size, the size-distribution of ssDNA could be
estimated by using the coordination of bands in the ladder.
Estimation of the size-distribution of undigested DNA, that
did not migrate into the gel efficiently, could not be achieved
as that fraction includes large DNA molecules of various
sizes that are not resolved in the gel. Statistical analysis of
repair experiments was done with Student’s t-test.
Alkaline comet assay
Formation of interstrand crosslinks was analyzed with the
alkaline comet assay (30,31). Confluent BJ cell cultures in
T25 flasks were treated with 5 g/ml cisplatin in serum free
medium or 0.5–5 g/ml MMC for 24 h in media containing
10% serum. At the end of treatment, medium was removed
and cells were further treated with PBS containing 100 M
hydrogen peroxide (H2O2) for 15 min at 37◦C to induce for-
mation of DNA breaks (30). Cells were then trypsinized
with 0.05% trypsin, PBS was added for total volume of 1
ml, and the cells were counted using Countess Automated
Cell Counter (Life Technologies) after trypan blue stain-
ing. Cells were centrifuged at 1000 rpm for 1 min and re-
suspended in ice-cold PBS at 1 × 105 cells/ml. The alka-
line comet assay was then carried out using a CometAssay
Kit (Trevigen, Gaithersburg, MD, USA cat no. 3950-075-
02) according to the manufacturer’s instructions. Cells were
mixed with molten 1% LM Agarose (1:10 cell suspension to
agarose ratio) (Trevigen, cat. no. 4250-050-02) and 50 l of
the mixture were placed on the slide. The gel was allowed
to solidify at 4◦C for 10 min. The slides were first incubated
with lysis solution on ice for 1 h and then in alkali unwind-
ing solution (pH>13, 300 mM NaOH, 1 mM EDTA) at
room temperature for 30 min. Alkaline comet assay elec-
trophoresis was carried out in alkaline electrophoresis solu-
tion (pH >13, 300 mM NaOH, 1 mM EDTA) at 1 Volt/cm
and 300 mA, with the slides placed equidistant from the
electrodes in a Wide Mini-Sub Cell GT (BioRad) at 4◦C
for 40 min. After electrophoresis, the slides were washed
two times in 100 ml H2O for 5 min, once in 100 ml 70%
ethanol and then allowed to air dry at 37◦C for 15 min.
The DNA was stained with 1× SYBR Green I (Molecu-
lar Probes, Eugene, OR, USA) in TE buffer (10 mM Tris,
1 mM EDTA, pH 7.5) and visualized with LSM 5 Pascal
(Zeiss) fluorescent confocal microscope. The Comet images
were analyzed using ImageJ software (NIH) for tail mo-
ment (fraction of DNA in the tail × tail length), and 100
comets were scored in triplicate experiments for each sam-
ple. Control cells CC0–CC3 (Trevigen cat no. 4256-010-CC)
with standardized DNA damage were run with the samples.
Adaptor ligation
Adaptors N Bam 12 (5′-GATCCTCCCTCG-3′) and N
Bam 24 (5′-AGGCAACTGTGCTATCCGAGGGAG-3′)
(32) were ligated to Mbo I-digested human genomic DNA.
The reaction included 100 pmols of each primer, 1 g
DNA template, 3 l ligation buffer (Fermentas) and 1,3
mM MgCl2 in a final volume of 28 l. The sample was
heated to 55◦C and the temperature lowered to 4◦C at the
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of T4 DNA ligase (Fermentas) added at 4◦C for a final
volume of 30 l. The ligation reaction was at 15◦C for 16
h. After ligation, polymerase extension was carried out at
68◦C for 10 min, with dNTP’s (0.2 mM), 4 l 10 × poly-
merase buffer (Finnzymes) and 4 U Dynazyme polymerase
(2 U/l, Finnzymes) in a final volume of 40 l.
DNA elution, PCR and agarose electrophoresis
Each fraction of adaptor-ligated and cisplatin-treated DNA
was characterized using ImageQuant 5.1 software. The im-
age was printed out on an overhead and the gel cut ac-
cording to separation lines. DNA from gel parts was sub-
sequently eluted in 700 l 0,1 × TLE in 1500 l Eppen-
dorf tubes at 4◦C overnight at constant shaking. After elu-
tion, the liquid was removed from the gel and the sample
was then concentrated to 70 l using SpeedVac plus (Sa-
vant). Polymerase chain reaction (PCR) on DNA eluted
from gel parts was subsequently carried out with primer N
Bam24. The PCR included 4 l of DNA eluted from the gel,
1 x PCR buffer (4 mM MgCl2, Idaho), 0.2 pmol/l primer
N Bam24, 0.2 mM each dNTP, 2.5 U KlenTaq1 polymerase
(25 u/l, AB Peptides) in a final volume of 20 l. PCR
was carried out in a Veriti 96 Well Thermal Cycler (Ap-
plied Biosystems) and consisted of denaturation at 94◦C for
3 min, followed by 30 cycles of 94◦C for 30 s, 60◦C 45 s and
68◦C for 1 min, followed by elongation at 68◦C for 7 min.
PCR products were analyzed with electrophoresis in 1.7%
agarose. Apoptosis ladder detection was carried out with 4
g DNA on 2% agarose gels at 70 V for 90 min.
RESULTS
Detection of crosslinks on NLA
Cisplatin, a well known crosslinking agent (33), was used
to demonstrate that NLA could detect crosslinks in com-
plex DNA samples in solution (Figure 2 and Supplemen-
tary Figure S2). In the original DNA sample, only undam-
aged DNA was seen. After incubation for 16 h at 37◦C
without cisplatin, a small amount of ssDNA had formed,
presumably representing heat-induced damage and denatu-
ration. Lesions induced with cisplatin were easily detected
(Figure 2A). DNA migrating behind normal DNA was ob-
served indicating interstrand crosslinks (arc to left of the
dsDNA marker). Intrastrand DNA crosslinks bend DNA
molecules to a differing degree depending on the damag-
ing agent (33–36). DNA that migrated in front of the ds-
DNA arc corresponded to DNA molecules that were bent.
Formation of ssDNA presumably occurred because a high
number of intrastrand crosslinks and monoadducts caused
denaturation of dsDNA. The DNA damage detected was
dose-dependent (Supplementary Figure S2C).
The arc behind normal dsDNA could result from slower
migration in the second dimension electrophoresis because
of interstrand crosslinks, or relatively faster migration ve-
locity of nucleic acids the first dimension, for example due
to induction of the shorter A-helix DNA (37). To test
this, a less complex sample with clearly identifiable and
traceable bands was treated with cisplatin and analyzed
with NLA (Figure 2B). Formation of interstrand DNA
crosslinks caused the strands to remain covalently attached
and migrate slower in the second dimension electrophoresis
of NLA as seen, e.g. with the green bands migrating behind
the 221 bp fragment. Fragments with intrastrand crosslinks
migrated slower in the first dimension because of bending.
After the second dimension they are placed in front of larger
undamaged DNA fragments and vertically above the un-
damaged counterpart. This was also seen, e.g. with 221 bp
DNA fragments placed in front of the 396 bp fragment. An
alternative explanation would be that the band in front of
the 396 bp band results from nicking. This is unlikely since
non-specific nicking generates a smear that fades out (see
later) and cisplatin in general does not form nicks in purified
DNA. With longer incubation the bands become blurred
indicating increased number of lesions per molecules in-
cluding presumably formation of molecules with both in-
terstand and instrastrand crosslinks.
We tested if DNA crosslinks could be detected in cell cul-
tures treated with crosslinking agents. GM3440 cells, hu-
man fibroblasts with normal DNA repair, were treated with
different concentrations of crosslinking agents. Treatment
with biologically relevant concentrations of cisplatin (38)
for 8 h, ranging from 4 to 30 M, caused formation of the
same types of dose-dependent DNA lesions as previously
detected in DNA in solution (Figure 2C).
Confirmation of the migration behavior of DNA with inter-
strand crosslinks
Two experiments were done to test if the arc migrating
behind dsDNA was composed of DNA with interstrand
crosslinks. The first was to heat denature a cisplatin-treated
DNA sample before NLA. The original undamaged ds-
DNA sample that was heat treated prior to NLA migrated
as ssDNA (Figure 3A and B). In solution, interstrand DNA
crosslinks prevent full separation of DNA strands and cause
quick renaturation of DNA. This caused DNA with inter-
strand crosslinks to migrate in the same manner as with-
out heat treatment (Figure 3C and D). We also tested if
DNA fractions in the gel were amplifiable by PCR. Adap-
tors were ligated to Mbo I-digested DNA sample before
cisplatin-treatment, DNA from different arcs of the gel
was isolated after NLA and the eluted DNA was ampli-
fied with the adaptors as primers. Neither strand of ds-
DNA containing interstrand crosslinks can serve as tem-
plate. The PCR did not amplify products from DNA eluted
from the gel part behind dsDNA, further confirming that
the DNA migrating behind dsDNA contained interstrand
DNA crosslinks (Figure 3E–G). In contrast, DNA was am-
plified from other parts of the gel. DNA migrating in front
of dsDNA should contain intrastrand crosslinks on at least
one strand. As both strands were retarded in the first di-
mension electrophoresis, the intact complementary strands
also migrated in front of the dsDNA and were amplifiable
(Figure 3G, lane 6). The amplified material in Figure 3G
lane 2 presumably resulted from trailing fragments from
the dsDNA arc. The large amount of non-amplifiable mate-
rial in Figure 3G lane 5 presumably quenched amplification
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Figure 2. Cisplatin crosslinks in DNA detected with NLA. (A) Analysis of DNA crosslinks in a complex DNA sample. (a) Untreated but Mbo I-digested
human genomic DNA (green smear) migrated with the double-stranded Cy5-labeled marker. (b) The same DNA after incubation at 37◦C for 16 h showing
slight heat-induced damage. (c–e) DNA samples treated with the indicated concentration of cisplatin. Quantification of fractions of duplicate experiments
with standard deviations (SD) is shown. A significant increase in DNA migrating behind and in front of undamaged DNA was detected after treatment
with all concentrations of cisplatin (P < 0.05). (B) Abnormal migration of individual DNA molecules containing interstand crosslinks or adducts including
intrastand crosslinks detected with NLA. (a) Agarose analysis of GeneRuler 100 bp (lane 1) and sample pUC18 double-digested with Hinf I and SSp I
to generate individually recognized fragments (lane 2). (b) NLA of sample (green bands) and marker, (c and d) NLA of sample after treatment with 10
M cisplatin for indicated time. (C) Detection of DNA interstrand and intrastrand crosslinks in GM3440 fibroblast cell culture treated with different
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Figure 3. Confirmation that the DNA arc migrating behind normal dsDNA contained molecules with interstrand DNA crosslinks. (A–D) DNA in inter-
strand DNA arc was resistant to heat-denaturation. (A) The original undamaged MboI-digested human genomic DNA sample. (B) The original DNA
after heat denaturation. (C) DNA after treatment with 1 M cisplatin for 18 h. (D) DNA treated with cisplatin and heat denatured. (E–G) DNA in in-
terstrand arc was refractory to amplification. Adaptor-ligated human genomic DNA (E) before and (F) after treatment with 1 M cisplatin for 18 h was
eluted from different labeled arcs of 2D-SDE gels. (G) PCR products of eluted DNA on an agarose gel. M: GeneRuler 100 bp Plus marker. Lanes 1–3
DNA amplified from the control (lane 1: dsDNA arc, lane 2: fraction behind dsDNA, lane 3: fraction in front of dsDNA). Lanes 4–6 DNA amplified from
the cisplatin-treated sample (lane 4: dsDNA arc, lane 5: fraction behind dsDNA, lane 6: fraction in front of dsDNA. Lane 7: amplification in DNA-free
gel, lane 8: positive control, adaptor-ligated DNA before gel-loading, lane 9: blank (H2O).
Detection and repair of DNA crosslinks in FA cell lines with
NLA
We tested if NLA could be used to detect the different sen-
sitivity of FA and wild-type cell cultures to MMC, a com-
monly used agent for the diagnosis of FA. The following
cell lines were used: i) BJ, wild-type human fibroblasts; ii)
FANCA−/− +Vector, FA patient fibroblasts which have de-
fective DNA crosslink repair due to biallelic mutations in
the FANCA gene; iii) FANCA−/− +WT-FANCA, the same
FA fibroblasts transfected with a FANCA gene, which re-
stores their DNA crosslink repair; iv) FANCD1−/- FA pa-
tient fibroblasts which have defective DNA crosslink repair
due to biallelic mutations in the FANCD1/BRCA2 gene.
Cytogenetic abnormalities detected after treatment with
50 nM MMC for 24 h correlated with cell types (Supple-
mentary Figure S3 and Table S1). Fibroblast cultures were
treated with 0.5 g/ml and 5 g/ml MMC. DNA was iso-
lated immediately after MMC treatment ranging from 4–24
h. Damaged DNA detected by NLA was dose-dependent,
but did not correlate with cytogenetic abnormalities. After
treatment with 0.5 g/ml MMC limited DNA crosslinks
were detected in all cell types on NLA (Supplementary
Figure S4). More DNA damage was detected after treat-
ment with 5 g/ml MMC (Supplementary Figure S4). The
DNA damage detected included both interstrand and in-
trastrand DNA crosslinks at all time points. No differ-
ences in amount of DNA damage was detected between BJ,
FANCA−/− +WT-FANCA and the two repair deficient cell
lines. Treatment for 6–8 h did not increase DNA damage
compared to 4 h incubation. After MMC incubation for
24 h relatively more interstrand crosslinks were detected,
along with accumulation of ssDNA in the repair deficient
cell lines (compare Figure 4 to Supplementary Figure S4).
The ssDNA may reflect accumulation of replication inter-
mediates formed during the longer MMC incubation. DNA
crosslinks were also detected after treatment of BJ cell cul-
tures with different concentrations of DEB and melphalan
(Supplementary Figure S5).
We tested if NLA could detect differences in repair
of MMC damage between cells with wild type DNA re-
pair capacity (BJ and FANCA−/− +WT-FANCA cell lines)
and cells with defective DNA crosslink repair (FANCA−/−
+Vector and FANCD1−/− cell lines). Cell cultures were
treated with 5 g/ml MMC for 24 h and then allowed to
recover in a MMC-free medium for 24 or 48 h (Figure
4A–D). After the indicated repair time an increase in the






/nar/article-abstract/46/20/e118/5057061 by Landspitali U
niversity H
ospitals user on 29 M
arch 2019
e118 Nucleic Acids Research, 2018, Vol. 46, No. 20 PAGE 8 OF 13
Figure 4. NLA of repair activity in fibroblast cell cultures. (A–D) BJ, FANCA−/− +WT-FANCA, FANCA−/− +Vector and FANCD1−/− fibroblast cell
line cultures. Quantitative measurements after repair are shown for (E) dsDNA, (F) interstrand DNA crosslinks and (G) intrastrand DNA crosslinks. The
average percentage of each DNA fraction in triplicate experiments is shown, after no repair (black columns), 24 h repair (gray columns) and 48 h repair
(white columns). Asterisks indicate statistically significant P-values.
(P < 0.05) (Figure 4A and E) and a decrease in inter-
strand crosslinks (P = 0.02 after 24 h repair) (Figure 4F)
and DNA intrastrand crosslinks (P < 0.05) (Figure 4G).
In the complemented FANCA−/− +WT-FANCA cell line,
an increase in dsDNA and decrease in intrastrand and in-
terstrand crosslinks were also detected, but the decrease
in the percentage of interstrand crosslinks was not statis-
tically significant (P = 0.06 for 48 h repair) (Figure 4B
and E–G). Consistent with impaired DNA crosslink repair,
FANCA−/− and FANCD1−/− cells did not show a signifi-
cant increase in the percentage of dsDNA, nor a significant
decrease in either type of DNA crosslinks in the first 48 h
post MMC exposure (Figure 4C and D). We also treated the
cell cultures with 5 g/ml MMC for 8 h and allowed them
to recover in a MMC-free medium for 72–120 h so the cells
would enter replication phase (Supplementary Figure S6).
Effective repair of the interstrand crosslinks in the BJ and
the FANCA−/− +WT-FANCA cell lines was seen after 72
h repair, but not in the FANCA−/- +Vector cell line. The
DNA migrating in front of the dsDNA was removed in BJ
and FANCA−/− +WT-FANCA cell lines. In the FANCA−/−
+Vector cell line we observed increased DNA in front of
the dsDNA after 120 h repair compared to 72 h repair,
which could indicate accumulation of replication interme-
diates (Supplementary Figure S6).
Comparison of NLA and the comet assay in detection of DNA
crosslinks
The most common method currently used to detect DNA
crosslinks is the comet assay. We compared the detection of
DNA crosslinks with comet assay and NLA in BJ fibrob-
last cell cultures. The detection of crosslinks with the comet
assay was based on the reduction in tail moment when cells
treated with H2O2 alone were compared to cells treated with
H2O2 and either cisplatin or MMC (30). DNA damage was
not detected in an untreated control cell culture that did not
receive treatment (Figure 5A). After treatment with MMC
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Figure 5. Comparison of NLA and the comet assay in detecting DNA crosslinks in cultured BJ cells. The score for the comet assay experiment is given in
percentage of DNA in comet tails, for 100 scored comets in triplicate experiments. The difference in comet tail moment was not statistically relevant when
(A)untreated cells were compared to (B) cells treated with MMC alone (P = 0.47), but relevant difference was detected between (C) H2O2-treated cells
and (D) cells treated with both H2O2 and MMC (P < 0.05). The relative amount of interstrand and intrastrand DNA crosslinks for triplicate experiments
analyzed with NLA are given. Increased formation of both types of crosslinks was detected when (A)untreated cells were compared to (B) cells treated
with MMC alone (P < 0.05) and (D) after treatment with both H2O2 and MMC (P < 0.05).
comet assay, but both types of DNA crosslinks were de-
tected with NLA (Figure 5B). H2O2 treatment resulted in
increased DNA in tail in the comet assay (Figure 5C) and
interstrand crosslinks were detected as decreased size of tail
after treatment with both H2O2 and MMC (Figure 5D). In
addition, ssDNA that resulted from oxidative DNA damage
was detected with NLA after treatment with H2O2 alone
(Figure 5C). Both types of DNA crosslinks were detected
on NLA after treatment with H2O2 and MMC.
Detection of DNA breaks on NLA
We induced formation of SSB and DSB by treating undi-
gested human genomic DNA in solution with the site-
specific nicking enzyme Nt.BstNB I, which has a 5 bp recog-
nition sequence. The resulting SSB that were detected as
a horizontal streak migrating from the DNA fraction that
was too large to migrate into the gel (Figure 6A). Treatment
of undigested human genomic DNA with the site-specific
enzyme Nt.CviPII (3 bp recognition sequence) resulted in
the same effect, albeit as expected at lower concentration
of the enzyme since it is a more frequent cutter (data not
shown).
We induced formation of SSB and DSB in HUVEC
cell cultures using etoposide, a potent topoisomerase II
inhibitor and inducer of apoptosis (12). We detected
nucleosomal-sized double-stranded fragments of 180 and
360 bp (Figure 6B), that indicated an apoptosis ladder.
From each nucleosomal-sized fragment we could detect a
column that extended up to a horizontal streak extend-
ing from the fragments that were too large to enter the
gel efficiently. The streak represented SSB. Of note there
was increased density of material in the streak represent-
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Figure 6. NLA of SSB and DSB in DNA in solution and in cell culture. (A) Undigested human genomic DNA sample treated with different concentrations
of nicking enzyme N.BstNB I. (B) DNA from HUVEC cell cultures treated with etoposide or grown without FBS. (C) 2% agarose gels showing apoptosis
ladder in HUVEC cells deprived of FBS or after treatment with etoposide. Quantification with SD is shown.
ther confirmation that this pattern was due to apoptosis,
the HUVEC cell cultures were starved of serum. A sim-
ilar pattern of nucleosomal sized fragments and columns
was detected (Figure 6B). The horizontal streak of SSB was
less pronounced in the starved cells compared to etoposide-
treated cells. Formation of apoptotic ladder in these samples
was confirmed by analysis on agarose gels (Figure 6C).
BRCA2−/− cells are deficient in homologous recombi-
nation (HR) and depend on non-homologous end-joining
(NHEJ) pathways for DSB repair. PARP inhibitors cause
SSB formation that is subsequently converted to DSB by the
cellular replication machinery. In healthy replicating cells,
DSB are repaired by the HR pathway, whereas BRCA−/−
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if DNA breaks could be detected in cell cultures treated with
the PARP inhibitor olaparib, a selective inhibitor of PARP1
that effectively inhibits repair of ssDNA breaks. MCF-7
cells, which are BRCA2 wild type and the BRCA2 ± cell
line A176 had increased SSB after treatment with olaparib
(Figure 7A–D). The BRCA2−/− cell line Capan-1 had sub-
stantially more DSB after olaparib treatment compared to
the other two cell lines (Figure 7E and F).
DISCUSSION
We describe comprehensive detection of multiple types of
structural DNA lesions with NLA. The DNA lesions were
detected by their different effects on the mobility of DNA
molecules during NLA, resulting in the formation of dis-
tinctive migration patterns (Figure 1 and Supplementary
Figure S7). Different types of lesions were detected simul-
taneously. The sensitivity of NLA appeared comparable to
other methods for detection of interstrand DNA crosslinks
(39), and topoisomerase-induced breaks (9).
We have adapted the NLA to a microgel format where
the electrophoresis time is only 22 min (29). NLA is sim-
ple, robust and quantification of different DNA fractions
in the sample is straightforward. Using the microgel format
for NLA, as little as 5 ng sample of genomic DNA is needed
for analysis. The NLA protocol, including DNA isolation
and manipulation, can be completed in 5 h using a micro-
gel, which is comparable to the time needed for the comet
assay. While the comet assay can be carried out with fewer
cells than NLA, a greater technical skill is needed for the
comet assay. The cost of reagents and consumables for the
two methods is similar.
Both NLA and the comet assay were able to detect DNA
interstrand crosslinks (Figure 5), although several differ-
ences were observed between the two methods. Interstrand
DNA crosslinks were detected via a modified comet assay
in which cell nuclei were treated with a standard genotoxic
agent to generate a tail of broken DNA fragments of cer-
tain size upon electrophoresis. A decrease in the tail mo-
ment indicates the presence of interstrand crosslinks that
retard migration of DNA fragments (15,40). In contrast,
NLA allows direct detection of DNA with crosslinks with-
out using an extra genotoxic agent. It is therefore not influ-
enced by variation in the effect of DNA-damaging agents,
like H2O2 or ionizing radiation. The NLA method was able
to analyze DNA molecules with both intra- and interstrand
crosslinks along with damage causing DNA denaturation,
while the comet assay could detect only DNA with inter-
strand crosslinks. The separation of DNA fractions with
different types of DNA damage allows the researcher to iso-
late DNA from each fraction for further analysis of their
composition. Importantly, DNA recovered from different
arcs of NLA can be analyzed in order to test if specific mo-
tifs or genomic regions are more prone to form crosslinks. In
vitro experiments have for instance revealed that methylated
CpG sites are preferentially crosslinked with MMC (41).
DNA breaks can also be detected on NLA (Figure 1
and Supplementary Figure S7). Therefore, NLA can de-
tect apoptosis ladders in undigested DNA samples as ds-
DNA nucleosomal-sized fragments migrating with the ds-
DNA marker (Figure 6). Of interest, besides the classical
apoptosis ladder formed by CAD endonuclease, NLA can
detect long fragments with SSB possibly generated with
parthanatos and endoG nuclease, respectively (42,43). In
addition, we detect vertical columns that extend upward
from each nucleosomal-sized fragment into the horizon-
tal streak resulting from SSB. The reason for the forma-
tion of the vertical columns is unclear, but they might re-
flect bending lesions retarded in the first dimension or more
likely incomplete nicking in the DNA fragments as an inter-
mediate in formation of the nucleosomal-sized fragments.
Since single-stranded oligonucleotides can also be detected
on NLA, the technique can be used to assess a much greater
scope of stages of programmed cell death than is possible
with a 1D agarose ladder. For example, the NLA apopto-
sis pattern after etoposide-treatment showed increased for-
mation of SSB compared to the pattern for serum-starved
cells (Figure 6), but this difference was not detected on
agarose. This could indicate a difference in the programmed
cell death caused by etoposide compared to serum starva-
tion, as has previously been reported (44). In addition, we
primarily detect formation of SSB and DSB when using
NLA to analyze DNA from cells treated with the PARP1
inhibitor olaparib (Figure 7). The increased accumulation
of DSB detected in the Capan-1 BRCA2−/- compared to
other cell lines is presumably due to their failure to repair
strand breaks with HR.
Using NLA we found repair of MMC-induced DNA
damage to be more effective in cell lines with normal
DNA crosslink repair compared to DNA crosslink repair-
deficient FA mutated cell lines, but both cell types contained
similar numbers of induced DNA lesions prior to post-
exposure repair. The repair of interstrand DNA crosslinks
appeared to be less effective compared to the repair of
intrastrand crosslinks. This may reflect that interstrand
crosslinks are not fully repaired until the cell has started
replication of the DNA (45). DNA migrating in front of
normal DNA in MMC-treated FA mutated cell lines did not
decrease after recovery in MMC-free medium (Figure 4C
and D). In addition to intrastrand DNA crosslinks, other
DNA molecules could potentially cause this type of NLA
pattern. For example, replication intermediates would be
detected by their migration in front of the normal DNA.
An important advantage of NLA is the ability to ana-
lyze DNA damage in cell-free systems (Figures 2 and 6).
This would, e.g. allow analysis of DNA damage in body
fluids, including plasma, saliva and urine, which is not pos-
sible with the comet assay. The sensitivity of the microgel
system is adequate for analysis of DNA lesions in body flu-
ids that may reflect disease state or response to therapy. Of
particular interest would be studying the effects of radiation
and chemotherapy and to test if NLA could be a possible
method to test for ‘BRCAness’ (46). NLA analysis of puri-
fied DNA also has important applications in molecular pro-
cedures where crosslinks are formed such as Chip-Seq (21).
NLA allows easy testing of the quality of DNA samples in
biobanks and for genotoxicity both in naked DNA as well
as in biological systems. A concern in genotoxicity testing is
the sensitivity of the method, as some other methods might
be more sensitive with regards to low concentration of par-
ticular DNA damage inducing agents. However, no meth-
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Figure 7. Detection of PARP1 inhibitor-induced breaks in cell cultures treated with olaparib. (A) Untreated MCF-7 cells (BRCA2+/+), (B) MCF-7 cells af-
ter treatment with olaparib, (C) untreated A176 cells (BRCA2−/+), (D) olaparib-treated A176 cells, (E) untreated Capan-1 cells (BRCA2−/−), (F) olaparib-
treated Capan-1 cells. Quantification with SD is shown.
DNA damage at the same time. NLA might therefore be the
method of choice for screening for various genotoxic effects.
SUPPLEMENTARY DATA
Supplementary Data are available at NAR Online.
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